4/A: Myomo Inc. Chief Medical Officer Harry Kovelman Amends SEC Filing Regarding Stock Transaction

Harry Kovelman, Chief Medical Officer of Myomo, Inc., amended a previous SEC filing to correct the coding of a transaction involving the disposition of 5,347 shares of common stock to cover income taxes.

Summary

• Harry Kovelman, the Chief Medical Officer of Myomo, Inc., filed an amendment to a Form 4 with the SEC.
• The amendment corrects the coding of a transaction from an acquisition to a disposition of shares.
• On June 10, 2024, Kovelman disposed of 5,347 shares of Myomo common stock at an average price of $3.379 per share.
• The shares were sold to cover income taxes resulting from the vesting of restricted stock units on June 8 and June 9, 2024.
• Following the transaction, Kovelman directly owns 145,541 shares of Myomo common stock.
• The original filing was made on June 12, 2024, and the amendment was filed on July 2, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider transactions, with no inherent positive or negative sentiment. It's a factual report of a stock sale to cover tax obligations.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on stakeholders.

Key Dates